126 related articles for article (PubMed ID: 27198909)
1. Challenging 'girls only' publicly funded human papillomavirus vaccination programmes.
Law VG; Gustafson DL
Nurs Inq; 2017 Jan; 24(1):. PubMed ID: 27198909
[TBL] [Abstract][Full Text] [Related]
2. Canadian school-based HPV vaccine programs and policy considerations.
Shapiro GK; Guichon J; Kelaher M
Vaccine; 2017 Oct; 35(42):5700-5707. PubMed ID: 28893472
[TBL] [Abstract][Full Text] [Related]
3. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
Moss JL; Reiter PL; Brewer NT
Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.
McClure CA; MacSwain MA; Morrison H; Sanford CJ
Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789
[TBL] [Abstract][Full Text] [Related]
5. A Multiple Streams analysis of the decisions to fund gender-neutral HPV vaccination in Canada.
Shapiro GK; Guichon J; Prue G; Perez S; Rosberger Z
Prev Med; 2017 Jul; 100():123-131. PubMed ID: 28435081
[TBL] [Abstract][Full Text] [Related]
6. Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010.
Laugesen MJ; Mistry R; Carameli KA; Ribisl KM; Needleman J; Bastani R
J Adolesc Health; 2014 Nov; 55(5):659-64. PubMed ID: 24928803
[TBL] [Abstract][Full Text] [Related]
7. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
Lehtinen M; Apter D
Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
Poljak M
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
[TBL] [Abstract][Full Text] [Related]
9. Differences in Human Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus Non-metropolitan Areas: Considering the Moderating Roles of Maternal Socioeconomic Status and Health Care Access.
Monnat SM; Rhubart DC; Wallington SF
Matern Child Health J; 2016 Feb; 20(2):315-25. PubMed ID: 26511129
[TBL] [Abstract][Full Text] [Related]
10. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
[TBL] [Abstract][Full Text] [Related]
11. Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study.
Georgousakis M; Jayasinghe S; Brotherton J; Gilroy N; Chiu C; Macartney K
Lancet Infect Dis; 2012 Aug; 12(8):627-34. PubMed ID: 22445354
[TBL] [Abstract][Full Text] [Related]
12. Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents.
Hansen BT; Campbell S; Burger E; Nygård M
Prev Med; 2015 Aug; 77():4-10. PubMed ID: 25944266
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
Owsianka B; Gańczak M
Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
[TBL] [Abstract][Full Text] [Related]
14. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates.
Jeudin P; Liveright E; Del Carmen MG; Perkins RB
Clin Ther; 2014 Jan; 36(1):24-37. PubMed ID: 24417783
[TBL] [Abstract][Full Text] [Related]
15. Adolescent HPV vaccination: empowerment, equity and ethics.
Sundaram N; Voo TC; Tam CC
Hum Vaccin Immunother; 2020 Aug; 16(8):1835-1840. PubMed ID: 31860406
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccine introduction--the first five years.
Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013.
Raesima MM; Forhan SE; Voetsch AC; Hewitt S; Hariri S; Wang SA; Pelletier AR; Letebele M; Pheto T; Ramogola-Masire D; El-Halabi S
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(40):1147-9. PubMed ID: 26468997
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
19. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
Osazuwa-Peters N
Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
